Vlado Perkovic's Publications
About Vlado Perkovic's Publications
Board Member- MBBS,
- PhD,
- FASN,
- FRACP
-
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
New England Journal of Medicine Date published: -
The modifiable burden of worldwide mortality from cardiovascular diseases
The Lancet Diabetes & Endocrinology Date published: -
The modifiable burden of worldwide mortality from cardiovascular diseases
The Lancet Diabetes & Endocrinology Date published: -
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
The Lancet Date published: -
Effect of Hemodiafiltration or Hemofiltration Compared With Hemodialysis on Mortality and Cardiovascular Disease in Chronic Kidney Failure: A Systematic Review and Meta-analysis of Randomized Trials
American Journal of Kidney Diseases Date published: -
Is it time for Medi-change?
Medical Journal of Australia Date published: -
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Cochrane Database of Systematic Reviews Date published: -
The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy
Journal of the American Society of Nephrology Date published: -
Kidney Disease in Diabetes
Managing Cardiovascular Complications in Diabetes Date published: -
HMG CoA reductase inhibitors (statins) for kidney transplant recipients
Cochrane Database of Systematic Reviews Date published: -
Authors' reply to Ladapo and Ogedegbe
BMJ Date published: -
DIETARY SODIUM REDUCTION REDUCED ALBUMINURIA IN 1,903 RURAL CHINESE: A CLUSTER RANDOMISED TRIAL
Date published: -
Long-term Efficacy and Safety of Linagliptin in Type 2 Diabetes Patients with Moderate to Severe Renal Disease
Date published: -
RESEARCH PRIORITIES IN CHRONIC KIDNEY DISEASE: A PRIORITY SETTING PARTNERSHIP
Date published: -
Establishing a clinical trials network in nephrology: experience of the Australasian Kidney Trials Network
Kidney International Date published: -
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Sao Paulo Medical Journal Date published: